Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
Orange, CA
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
San Diego, CA
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
Bay Pines, FL
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
Bay Pines, FL
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
Gainesville, FL
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
Jacksonville, FL
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
Miami, FL
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
Orlando, FL
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
St Petersburg, FL
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
St Petersburg, FL
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
Chicago, IL
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
Springfield, IL
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
Springfield, IL
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
Covington, LA
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
Covington, LA
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
Shreveport, LA
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
Baltimore, MD
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
Minneapolis, MN
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
St Louis, MO
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
St Louis, MO
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
Albany, NY
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
Albany, NY
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
Cleveland, OH
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
Tulsa, OK
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
Charleston, SC
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
Columbia, SC
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
Columbia, SC
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
Amarillo, TX
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
Amarillo, TX
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
Houston, TX
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
Richmond, VA
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
Tacoma, WA
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
Clinical Research Facility
mi
from
Madison, WI
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated:  12/15/2015
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Halifax,
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Status: Enrolling
Updated: 12/15/2015
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Halifax,
Click here to add this to my saved trials
Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
A Multi-Center, Open-label Pilot Study of Abatacept (CTLA4-Ig) in the Treatment of Mild Relapsing Wegener's Granulomatosis
Status: Enrolling
Updated:  12/15/2015
The Johns Hopkins Vasculitis Center
mi
from
Baltimore, MD
Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
A Multi-Center, Open-label Pilot Study of Abatacept (CTLA4-Ig) in the Treatment of Mild Relapsing Wegener's Granulomatosis
Status: Enrolling
Updated: 12/15/2015
The Johns Hopkins Vasculitis Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
A Multi-Center, Open-label Pilot Study of Abatacept (CTLA4-Ig) in the Treatment of Mild Relapsing Wegener's Granulomatosis
Status: Enrolling
Updated:  12/15/2015
Boston University School of Medicine
mi
from
Boston, MA
Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
A Multi-Center, Open-label Pilot Study of Abatacept (CTLA4-Ig) in the Treatment of Mild Relapsing Wegener's Granulomatosis
Status: Enrolling
Updated: 12/15/2015
Boston University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
A Multi-Center, Open-label Pilot Study of Abatacept (CTLA4-Ig) in the Treatment of Mild Relapsing Wegener's Granulomatosis
Status: Enrolling
Updated:  12/15/2015
Mayo Clinic College of Medicine
mi
from
Rochester, MN
Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
A Multi-Center, Open-label Pilot Study of Abatacept (CTLA4-Ig) in the Treatment of Mild Relapsing Wegener's Granulomatosis
Status: Enrolling
Updated: 12/15/2015
Mayo Clinic College of Medicine
mi
from
Rochester, MN
Click here to add this to my saved trials
Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
A Multi-Center, Open-label Pilot Study of Abatacept (CTLA4-Ig) in the Treatment of Mild Relapsing Wegener's Granulomatosis
Status: Enrolling
Updated:  12/15/2015
Cleveland Clinic
mi
from
Cleveland, OH
Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
A Multi-Center, Open-label Pilot Study of Abatacept (CTLA4-Ig) in the Treatment of Mild Relapsing Wegener's Granulomatosis
Status: Enrolling
Updated: 12/15/2015
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Bradykinin Receptor Blocker in ACE Inhibitor-associated Angioedema
Study of a Bradykinin Receptor Blocker in Angiotensin Converting Enzyme Inhibitor-Associated Angioedema
Status: Enrolling
Updated:  12/16/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
Bradykinin Receptor Blocker in ACE Inhibitor-associated Angioedema
Study of a Bradykinin Receptor Blocker in Angiotensin Converting Enzyme Inhibitor-Associated Angioedema
Status: Enrolling
Updated: 12/16/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Stroke Prevention With Abciximab in Carotid Endarterectomy
Stroke Prevention With Abciximab in Carotid Endarterectomy
Status: Enrolling
Updated:  12/17/2015
University of Rochester Medical Center-Strong Memorial Hospital
mi
from
Rochester, NY
Stroke Prevention With Abciximab in Carotid Endarterectomy
Stroke Prevention With Abciximab in Carotid Endarterectomy
Status: Enrolling
Updated: 12/17/2015
University of Rochester Medical Center-Strong Memorial Hospital
mi
from
Rochester, NY
Click here to add this to my saved trials
99th Percentile Upper Reference Limit (URL) for the Meritas Troponin I Test
Using Normal Volunteer Whole Blood or Plasma Samples to Establish the 99th Percentile Upper Reference Limit (URL) for the Meritas Troponin I Test
Status: Enrolling
Updated:  12/17/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
99th Percentile Upper Reference Limit (URL) for the Meritas Troponin I Test
Using Normal Volunteer Whole Blood or Plasma Samples to Establish the 99th Percentile Upper Reference Limit (URL) for the Meritas Troponin I Test
Status: Enrolling
Updated: 12/17/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
99th Percentile Upper Reference Limit (URL) for the Meritas Troponin I Test
Using Normal Volunteer Whole Blood or Plasma Samples to Establish the 99th Percentile Upper Reference Limit (URL) for the Meritas Troponin I Test
Status: Enrolling
Updated:  12/17/2015
Medical Research South
mi
from
Charleston, SC
99th Percentile Upper Reference Limit (URL) for the Meritas Troponin I Test
Using Normal Volunteer Whole Blood or Plasma Samples to Establish the 99th Percentile Upper Reference Limit (URL) for the Meritas Troponin I Test
Status: Enrolling
Updated: 12/17/2015
Medical Research South
mi
from
Charleston, SC
Click here to add this to my saved trials
99th Percentile Upper Reference Limit (URL) for the Meritas Troponin I Test
Using Normal Volunteer Whole Blood or Plasma Samples to Establish the 99th Percentile Upper Reference Limit (URL) for the Meritas Troponin I Test
Status: Enrolling
Updated:  12/17/2015
Tanner Clinic
mi
from
Layton, UT
99th Percentile Upper Reference Limit (URL) for the Meritas Troponin I Test
Using Normal Volunteer Whole Blood or Plasma Samples to Establish the 99th Percentile Upper Reference Limit (URL) for the Meritas Troponin I Test
Status: Enrolling
Updated: 12/17/2015
Tanner Clinic
mi
from
Layton, UT
Click here to add this to my saved trials
Multivariable Assessment of Coronary Artery Disease Using Cardiac CT Imaging
Multivariable Assessment of Coronary Artery Disease Using Cardiac CT Imaging
Status: Enrolling
Updated:  12/18/2015
University of Chicago
mi
from
Chicago, IL
Multivariable Assessment of Coronary Artery Disease Using Cardiac CT Imaging
Multivariable Assessment of Coronary Artery Disease Using Cardiac CT Imaging
Status: Enrolling
Updated: 12/18/2015
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
mi
from
Birmingham, AL
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
mi
from
Little Rock, AR
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
mi
from
San Diego, CA
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
mi
from
Newark, DE
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
mi
from
Newark, DE
Click here to add this to my saved trials
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
mi
from
Washington,
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
mi
from
Atlanta, GA
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
mi
from
Honolulu, HI
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
mi
from
Honolulu, HI
Click here to add this to my saved trials
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
mi
from
Louisville, KY
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
mi
from
Baltimore, MD
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
mi
from
Ayer, MA
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
mi
from
Ayer, MA
Click here to add this to my saved trials
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
mi
from
Detroit, MI
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials